Louis G. Lange, Director at Audentes Therapeutics, Inc. (BOLD), sold 51,000 shares at $18.67 ($951K) on 2018-12-24, disclosed to the SEC on 2018-12-27.
Open-market sale of $950k BOLD by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.50 | 10,000 | $185K | 19.5% |
| 2 | $18.67 | 20,000 | $373K | 39.3% |
| 3 | $18.67 | 20,000 | $373K | 39.3% |
| 4 | $18.70 | 1,000 | $19K | 2.0% |
| Total | $18.64 avg | 51,000 | $951K | 100% |
| Filing → |
| NAMS | BUY | 2024-02-21 | $95K | — | Filing → |
| BOLD | SELL | 2019-12-27 | $656K | — | Filing → |
| BOLD | SELL | 2019-09-25 | $667K | — | Filing → |